The patients were stratified into two subgroups each according to age, sex, BMI, hypertension, dyslipidemia, type of AMI, LVEF, oral hypoglycemic agent use, insulin use, and newly diagnosed diabetes. This evidence concerns the gene INS and diabetes mellitus.